Existence of pattern 5 on radical prostatectomy: Poor prognostic factor associated with a lower biochemical recurrence-free survival

被引:0
|
作者
Pastori, J. [1 ,2 ]
Balssa, L. [1 ,2 ]
Lillaz, J. [3 ]
Guichard, G. [1 ]
Chabannes, E. [1 ]
Bernardini, S. [1 ]
Bittard, H. [1 ,2 ]
Thiery-Vuillemin, A. [2 ,4 ,5 ]
Kleinclauss, F. [1 ,2 ,5 ]
机构
[1] CHRU Besancon, Ser Urol & Transplantat Renale, F-25003 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] CHI Haute Saone, Serv Urol, F-25000 Vesout, France
[4] CHRU Besancon, Serv Oncol Med, F-25000 Besancon, France
[5] Inserm, UMR 1098, F-25000 Besancon, France
来源
PROGRES EN UROLOGIE | 2014年 / 24卷 / 07期
关键词
Oncological outcomes; Prostate Cancer; Radical prostatectomy; Gleason pattern 5; Adverse pathological factors; GLEASON GRADE; CANCER;
D O I
10.1016/j.purol.2014.03.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - To analyze the impact of the existence of Gleason grade 5 on the adverse pathology and biochemical recurrence-free survival of patients. Patients. - Three hundred and seventy-two prostatectomies were performed between 1999 and 2011 in our institution for localised prostate adenocarcinoma. We examined the existence of grade 5 of the specimen to determine the reliability of prostate biopsies in the diagnosis of grade 5 and the association of grade 5 with other histoprognostic factors. Biochemical recurrence-free survival was analyzed according to the presence of grade Sin the final specimen. Results. - In total, all histological data and biochemical recurrence-free survival were available for 321 patients who were included in the study. Sixty-eight had Gleason grade 5 (majority or third minority pattern) on the specimen while 253 had not. Grade 5, rarely diagnosed on biopsy (sensitivity = 26.47%) was correlated independently with the extracapsular extension (OR = 2.1; CI 95 [1.1-3.9]), the seminal vesicle invasion (OR = 3.8; CI 95 [1.7-8.7]) and positive surgical margins (OR = 2.0; CI 95 [1.1-3.6]). Overall survival was similar in both groups but the biochemical recurrence-free survival was statistically lower in the presence of grade 5 (HR = 3.7; CI 95 [1.8-7.6]). Biochemical recurrence-free survival was not different than grade 5 is predominant or third minority pattern (HR = 1.01; CI 95 [0.3-2.8]). On multivariate analysis, grade 5 was an independent risk factor for biochemical recurrence (P = 0.005) as well as seminal vesicle invasion (P = 0.047). Conclusion. - The existence of grade Sin the surgical specimen whatever the percentage was a poor prognostic factor associated with increased tumor aggressiveness and reduced biochemical recurrence-free survival. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 50 条
  • [1] Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy
    Leandro Blas
    Masaki Shiota
    Dai Takamatsu
    Fumio Kinoshita
    Takashi Matsumoto
    Ken Lee
    Keisuke Monji
    Eiji Kashiwagi
    Junichi Inokuchi
    Masatoshi Eto
    World Journal of Urology, 2023, 41 : 43 - 50
  • [2] Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy
    Blas, Leandro
    Shiota, Masaki
    Takamatsu, Dai
    Kinoshita, Fumio
    Matsumoto, Takashi
    Lee, Ken
    Monji, Keisuke
    Kashiwagi, Eiji
    Inokuchi, Junichi
    Eto, Masatoshi
    WORLD JOURNAL OF UROLOGY, 2023, 41 (01) : 43 - 50
  • [3] Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
    Roberts, Matthew J.
    Morton, Andrew
    Papa, Nathan
    Franklin, Anthony
    Raveenthiran, Sheliyan
    Yaxley, William J.
    Coughlin, Geoffrey
    Gianduzzo, Troy
    Kua, Boon
    McEwan, Louise
    Wong, David
    Delahunt, Brett
    Egevad, Lars
    Samaratunga, Hemamali
    Brown, Nicholas
    Parkinson, Robert
    Emmett, Louise
    Yaxley, John W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3289 - 3294
  • [4] Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
    Matthew J. Roberts
    Andrew Morton
    Nathan Papa
    Anthony Franklin
    Sheliyan Raveenthiran
    William J. Yaxley
    Geoffrey Coughlin
    Troy Gianduzzo
    Boon Kua
    Louise McEwan
    David Wong
    Brett Delahunt
    Lars Egevad
    Hemamali Samaratunga
    Nicholas Brown
    Robert Parkinson
    Louise Emmett
    John W. Yaxley
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3289 - 3294
  • [5] Impact of Subcutaneous Fat Thickness on Biochemical Recurrence and Recurrence-Free Survival in Patients Undergoing Radical Prostatectomy
    Efiloglu, Ozgur
    Iplikci, Ayberk
    Gunduz, Nesrin
    Dogan, Mahmut Bilal
    Cakici, Mehmet Caglar
    Yildirim, Asif
    KONURALP TIP DERGISI, 2024, 16 (02): : 161 - 167
  • [6] Biochemical Recurrence-Free and Cancer-Specific Survival after Radical Prostatectomy at a Single Institution
    Kim, Seong Cheol
    Jeong, Ingab
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (12) : 836 - 842
  • [7] Predicting Biochemical Recurrence-Free Survival for Patients With Positive Pelvic Lymph Nodes at Radical Prostatectomy
    von Bodman, Christian
    Godoy, Guilherme
    Chade, Daher C.
    Cronin, Angel
    Tafe, Laura J.
    Fine, Samson W.
    Laudone, Vincent
    Scardino, Peter T.
    Eastham, James A.
    JOURNAL OF UROLOGY, 2010, 184 (01): : 143 - 148
  • [8] Recurrence-free Survival after radical Prostatectomy and PDE-5 Inhibitor Intake
    Hofer, L.
    Radtke, J. P.
    Rapp, C.
    Pahernik, S.
    Teber, D.
    Hohenfellner, M.
    Hadaschik, B.
    UROLOGE, 2017, 56 (04): : 492 - 496
  • [9] Reactive stroma in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy
    Yanagisawa, N
    Ayala, G
    Li, R
    Wheeler, TM
    MODERN PATHOLOGY, 2005, 18 : 173A - 173A
  • [10] Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer
    Han, M
    Partin, AW
    Piantadosi, S
    Epstein, JI
    Walsh, PC
    JOURNAL OF UROLOGY, 2001, 166 (02): : 416 - 419